Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL2387080 (GDC-0032, RG-7604, Taselisib) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
protein kinase, DNA-activated, catalytic subunit/DNA-dependent protein kinase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3142] [GtoPdb: 2800] [UniProtKB: P78527] | ||||||||
ChEMBL | Inhibition of DNA-dependent protein kinase (unknown origin) | B | 5.32 | pIC50 | >4800 | nM | IC50 | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
phosphatidylinositol 3-kinase catalytic subunit type 3/Phosphatidylinositol 3-kinase catalytic subunit type 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075165] [GtoPdb: 2152] [UniProtKB: Q8NEB9] | ||||||||
ChEMBL | Inhibition of human VPS34 | B | 6.43 | pIC50 | 374 | nM | IC50 | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL | Selectivity interaction (Enzymatic assay) EUB0000685a PIK3C3 | B | 6.43 | pIC50 | 374 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta/Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing beta polypeptide in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5554] [GtoPdb: 2151] [UniProtKB: O00750] | ||||||||
ChEMBL | Inhibition of PI3KC2beta (unknown origin) | B | 6.53 | pIC50 | 292 | nM | IC50 | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL | Selectivity interaction (Enzymatic assay) EUB0000685a PIK3C2B | B | 6.53 | pIC50 | 292 | nM | IC50 | Selectivity Literature for EUbOPEN Chemogenomics Library wave 3 |
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha/Phosphatidylinositol-4-phosphate 3-kinase C2 domain-containing subunit alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075102] [GtoPdb: 2150] [UniProtKB: O00443] | ||||||||
ChEMBL | Inhibition of PI3KC2alpha (unknown origin) | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha/PI3-kinase p110-alpha subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4005] [GtoPdb: 2153] [UniProtKB: P42336] | ||||||||
ChEMBL | Inhibition of recombinant PI3K alpha (unknown origin) using PIP2 as substrate by fluorescence polarization assay | B | 9.52 | pKi | 0.3 | nM | Ki | J Med Chem (2016) 59: 985-1002 [PMID:26741947] |
ChEMBL | Inhibition of PI3Kalpha (unknown origin) assessed as 3,4,5-inositoltriphosphate formation after 30 mins by fluorescence polarization assay | B | 9.54 | pKi | 0.29 | nM | Ki | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL | Affinity Biochemical interaction (Enzymatic fluorescence polarization assay) EUB0000685a PIK3CA | B | 9.54 | pKi | 0.29 | nM | Ki | Affinity Biochemical Literature for EUbOPEN Chemogenomics Library wave 3 |
GtoPdb | - | - | 9.54 | pKi | 0.29 | nM | Ki | J Med Chem (2013) 56: 4597-610 [PMID:23662903] |
ChEMBL | Inhibition of PI3Kalpha (unknown origin) using PIP2:3PS as substrate in presence of ATP measured after 120 mins by ADP-Glo assay | B | 10.05 | pKi | 0.09 | nM | Ki | J Med Chem (2022) 65: 16589-16621 [PMID:36455032] |
GtoPdb | - | - | 10.05 | pKi | 0.09 | nM | Ki | US20170015678. Benzoxazepin oxazolidinone compounds and methods of use (2017) |
ChEMBL | Inhibition of PI3Kalpha in human PC3 cells assessed as reduction of AKT phosphorylation | B | 7.51 | pIC50 | 31 | nM | IC50 | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL | Inhibition of PI3Kalpha in human MCF7-neo/Her2 cells assessed as reduction of AKT phosphorylation at S473 | B | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL | Affinity Phenotypic Cellular interaction (MesoScale Discovery assay (AKT phoshorylation in MCF 7 cells)) EUB0000685a PIK3CA | B | 8.4 | pIC50 | 4 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Inhibition of PI3K alpha (unknown origin) | B | 9.15 | pIC50 | <0.7 | nM | IC50 | ACS Med Chem Lett (2017) 8: 808-813 [PMID:28835793] |
ChEMBL | Inhibition of PI3Kalpha H1047R mutant in human HCC1954 cells assessed as reduction in PRAS40 phosphorylation after 24 hrs by electrochemiluminescent assay | B | 7.62 | pEC50 | 24 | nM | EC50 | J Med Chem (2022) 65: 16589-16621 [PMID:36455032] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta/PI3-kinase p110-beta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3145] [GtoPdb: 2154] [UniProtKB: P42338] | ||||||||
GtoPdb | - | - | 7.28 | pKi | 53 | nM | Ki | US20170015678. Benzoxazepin oxazolidinone compounds and methods of use (2017) |
GtoPdb | - | - | 8.04 | pKi | 9.1 | nM | Ki | J Med Chem (2013) 56: 4597-610 [PMID:23662903] |
ChEMBL | Inhibition of PI3Kbeta (unknown origin) | B | 8.04 | pKi | 9.1 | nM | Ki | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL | Affinity Biochemical interaction (Enzymatic fluorescence polarization assay) EUB0000685a PIK3CB | B | 8.04 | pKi | 9.1 | nM | Ki | Affinity Biochemical Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Affinity Phenotypic Cellular interaction (MesoScale Discovery assay (AKT phoshorylation in MCF 7 cells)) EUB0000685a PIK3CB | B | 8.4 | pIC50 | 4 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta/PI3-kinase p110-delta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3130] [GtoPdb: 2155] [UniProtKB: O00329] | ||||||||
GtoPdb | - | - | 9.68 | pKi | 0.21 | nM | Ki | J Med Chem (2013) 56: 4597-610 [PMID:23662903] |
ChEMBL | Inhibition of PI3Kdelta (unknown origin) | B | 9.92 | pKi | 0.12 | nM | Ki | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL | Affinity Biochemical interaction (Enzymatic fluorescence polarization assay) EUB0000685a PIK3CD | B | 9.92 | pKi | 0.12 | nM | Ki | Affinity Biochemical Literature for EUbOPEN Chemogenomics Library wave 3 |
GtoPdb | - | - | 10.1 | pKi | 0.08 | nM | Ki | US20170015678. Benzoxazepin oxazolidinone compounds and methods of use (2017) |
ChEMBL | Affinity Phenotypic Cellular interaction (MesoScale Discovery assay (AKT phoshorylation in MCF 7 cells)) EUB0000685a PIK3CD | B | 8.4 | pIC50 | 4 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Inhibition of PI3K delta (unknown origin) | B | 9.15 | pIC50 | <0.7 | nM | IC50 | ACS Med Chem Lett (2017) 8: 808-813 [PMID:28835793] |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736] | ||||||||
GtoPdb | - | - | 8.84 | pKi | 1.43 | nM | Ki | US20170015678. Benzoxazepin oxazolidinone compounds and methods of use (2017) |
GtoPdb | - | - | 9.01 | pKi | 0.97 | nM | Ki | J Med Chem (2013) 56: 4597-610 [PMID:23662903] |
ChEMBL | Inhibition of PI3Kgamma (unknown origin) | B | 9.01 | pKi | 0.97 | nM | Ki | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL | Affinity Biochemical interaction (Enzymatic fluorescence polarization assay) EUB0000685a PIK3CG | B | 9.01 | pKi | 0.97 | nM | Ki | Affinity Biochemical Literature for EUbOPEN Chemogenomics Library wave 3 |
ChEMBL | Affinity Phenotypic Cellular interaction (MesoScale Discovery assay (AKT phoshorylation in MCF 7 cells)) EUB0000685a PIK3CG | B | 8.4 | pIC50 | 4 | nM | IC50 | Affinity Phenotypic Cellular Literature for EUbOPEN Chemogenomics Library wave 3 |
mechanistic target of rapamycin kinase/Serine/threonine-protein kinase mTOR in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2842] [GtoPdb: 2109] [UniProtKB: P42345] | ||||||||
ChEMBL | Inhibition of mTOR (unknown origin) | B | 5.92 | pKi | 1200 | nM | Ki | J Med Chem (2013) 56: 4597-4610 [PMID:23662903] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]